Figures & data
Figure 1 Etiology of congestive heart failure in African Americans. Adapted from CitationCohn et al 1986; CitationCohn et al 1991; CitationThe SOLVD Investigators 1991; CitationPacker et al 1996; CitationMERIT-HF Study Group 1999;The Beta-Blocker Evaluation of Survival Trial Investigators 2001.
![Figure 1 Etiology of congestive heart failure in African Americans. Adapted from CitationCohn et al 1986; CitationCohn et al 1991; CitationThe SOLVD Investigators 1991; CitationPacker et al 1996; CitationMERIT-HF Study Group 1999;The Beta-Blocker Evaluation of Survival Trial Investigators 2001.](/cms/asset/8f4c6b5d-4cf6-43de-ad2e-9391daeec54d/dvhr_a_24423_f0001_b.jpg)
Figure 2 V-HeFT 1. survival benefit in subgroup analysis. Adapted from CitationCarson et al (1999).
![Figure 2 V-HeFT 1. survival benefit in subgroup analysis. Adapted from CitationCarson et al (1999).](/cms/asset/c7327d12-fc73-4dc1-b92d-21e052f6b906/dvhr_a_24423_f0002_b.jpg)
Figure 3 Consequences of nitric oxide and super oxide balance disruption in heart failure patients. Adapted from CitationHare (2004).
![Figure 3 Consequences of nitric oxide and super oxide balance disruption in heart failure patients. Adapted from CitationHare (2004).](/cms/asset/11875a14-6307-42e3-8fe3-3cd78a4d74ca/dvhr_a_24423_f0003_c.jpg)
Figure 4 Components of the composite score in A-HeFT.Adapted fromCitationTaylor et al (2004).
![Figure 4 Components of the composite score in A-HeFT.Adapted fromCitationTaylor et al (2004).](/cms/asset/9d1c4fb8-269e-4d9a-993f-4a68350d153d/dvhr_a_24423_f0004_b.jpg)